Cell and Gene Therapy

Update: novel disease-modifying treatments in development for Huntington’s disease 2:20
Update: novel disease-modifying treatments in development for Huntington’s disease
Anne Rosser • 23 Sep 2021
Phase I trial of fetal striatal cell transplantation in Huntington’s disease 2:58
Phase I trial of fetal striatal cell transplantation in Huntington’s disease
Anne Rosser • 23 Sep 2021
Novel treatment strategies for NMOSD 1:21
Novel treatment strategies for NMOSD
Kazuo Fujihara • 4 Oct 2021
Challenges in developing gene-based therapies for neurodegenerative & neuromuscular diseases 3:04
Challenges in developing gene-based therapies for neurodegenerative & neuromuscular diseases
Aida Abu-Baker • 11 Oct 2021
Approved gene-based therapies for neuromuscular diseases 3:56
Approved gene-based therapies for neuromuscular diseases
Aida Abu-Baker • 11 Oct 2021
RNA- and DNA- based therapies for neurodegenerative & neuromuscular diseases 13:42
RNA- and DNA- based therapies for neurodegenerative & neuromuscular diseases
Aida Abu-Baker • 11 Oct 2021
Gene-based therapies for neurodegenerative & neuromuscular diseases 3:23
Gene-based therapies for neurodegenerative & neuromuscular diseases
Aida Abu-Baker • 11 Oct 2021
CRISPR-Cas9 in vivo gene editing: a new frontier 1:58
CRISPR-Cas9 in vivo gene editing: a new frontier
Martin Ingelsson • 21 Sep 2021
CRISPR–Cas9 gene therapy for neurodegenerative diseases 4:05
CRISPR–Cas9 gene therapy for neurodegenerative diseases
Martin Ingelsson • 21 Sep 2021
The next steps in autism treatment: gene therapy 0:46
The next steps in autism treatment: gene therapy
James Clement • 20 Aug 2021
The potential of gene therapy and targeted treatments for epilepsy 2:18
The potential of gene therapy and targeted treatments for epilepsy
Iscia Lopes-Cendes • 16 Aug 2021
Gene therapy for pharmacoresistant epilepsy: principles, opportunities & difficulties 2:49
Gene therapy for pharmacoresistant epilepsy: principles, opportunities & difficulties
Simona Balestrini • 9 Aug 2021
Exciting developments in the field of epilepsy 1:35
Exciting developments in the field of epilepsy
Emilio Russo • 11 Aug 2021
Therapies in the pipeline for Huntington’s disease 1:54
Therapies in the pipeline for Huntington’s disease
Anne Rosser • 18 Jun 2021
Cell therapy in Huntington’s disease: where are we now? 2:58
Cell therapy in Huntington’s disease: where are we now?
Anne Rosser • 18 Jun 2021
Therapy strategies for Rett syndrome & MECP2 disorders 2:36
Therapy strategies for Rett syndrome & MECP2 disorders
Huda Zoghbi • 18 Jun 2021
The content of VJNeurology is intended for healthcare professionals